抗胸腺细胞球蛋白预防在血液恶性肿瘤患者接受异基因造血干细胞移植中的更新荟萃分析数据表5
该数据集为关于抗胸腺细胞球蛋白预防血液恶性肿瘤患者异基因造血干细胞移植后移植物抗宿主病的更新荟萃分析数据表。
基本信息
资源简介
抗胸腺细胞球蛋白预防在血液恶性肿瘤患者接受异基因造血干细胞移植中的更新荟萃分析数据表5
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 52.91 KB，主题涵盖 anti-thymocyte globulin、hematological malignancies、overall survival、meta-analysis，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《DataSheet_5_Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis.pdf》。配套论文《Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in Allogeneic Stem Cell Transplantation: Systematic Literature Review and Network Meta-Analysis》发表于 Biology of Blood and Marrow Transplantation（2017），DOI：10.1016/j.bbmt.2017.08.027。源站首次发布：2021-08-20。
【数据内容】
源站原始描述：BackgroundAnti-thymocyte globulin (ATG) prophylaxis reduces graft-versus-host disease (GVHD) incidence. This meta-analysis aimed to explore the long-term efficacy of ATG and the influencing factors in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). MethodsPubMed, Embase, and Cochrane databases were searched for the relevant studies published up to August 2020. Data from randomized controlled trials (RCTs) on ATG prophylaxis for GVHD prevention in allo-HSCT pat…
【数据结构与技术规格】
文件数 1 个，合计 52.91 KB。DataSheet_5_Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantat.pdf：application/pdf，52.91 KB。数据集 DOI：10.3389/fonc.2021.717678.s005。
【主题与分类】
源站学科分类：Cancer、Haematological Tumours、Molecular Targets、Radiation Therapy、Oncology and Carcinogenesis not elsewhere classified、Solid Tumours。主题标签：anti-thymocyte globulin、hematological malignancies、overall survival、meta-analysis。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://frontiersin.figshare.com/articles/dataset/DataSheet_5_Anti-Thymocyte_Globulin_Prophylaxis_in_Patients_With_Hematological_Malignancies_Undergoing_Allogeneic_Hematopoietic_Stem_Cell_Transplantation_An_Updated_Meta-Analysis_pdf/15602772
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Yang, Xue; Li, Dongjun; Xie, Yao (2021). DataSheet_5_Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis.pdf. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-05-31，引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：DataSheet_5_Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis.pdf
- DOI：10.3389/fonc.2021.717678.s005
- 发布日期：2021-08-20
- 文件数：1 个
- 文件总体积：52.91 KB
- 源站页面：https://frontiersin.figshare.com/articles/dataset/DataSheet_5_Anti-Thymocyte_Globulin_Prophylaxis_in_Patients_With_Hematological_Malignancies_Undergoing_Allogeneic_Hematopoietic_Stem_Cell_Transplantation_An_Updated_Meta-Analysis_pdf/15602772
命令行下载
curl -L -o "DataSheet_5_Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantat.pdf" "https://ndownloader.figshare.com/files/29589441"
文件清单
DataSheet_5_Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantat.pdf（52.91 KB）
文件总体积 52.91 KB（源站 API 实测）。
数据说明
BackgroundAnti-thymocyte globulin (ATG) prophylaxis reduces graft-versus-host disease (GVHD) incidence. This meta-analysis aimed to explore the long-term efficacy of ATG and the influencing factors in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT).
MethodsPubMed, Embase, and Cochrane databases were searched for the relevant studies published up to August 2020. Data from randomized controlled trials (RCTs) on ATG prophylaxis for GVHD prevention in allo-HSCT patients were extracted.
ResultsA total of eight relevant RCTs (1,348 patients) were included. ATG significantly reduced the incidence of grade III–IV aGVHD (P = 0.001) and cGVHD (P Although ATG had no significant effect on relapse, RFS, and NRM, it significantly reduced the occurrence and severity of GVHD, improved the GRFS, and reduced the number and dose of immunosuppressants in patients undergoing allo-HSCT.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fonc.2021.717678.s005（source: https://frontiersin.figshare.com/articles/dataset/DataSheet_5_Anti-Thymocyte_Globulin_Prophylaxis_in_Patients_With_Hematological_Malignancies_Undergoing_Allogeneic_Hematopoietic_Stem_Cell_Transplantation_An_Updated_Meta-Analysis_pdf/15602772）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
